Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (HKG:2196)

HKG:2196 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	11,478	13,524	13,694	16,241	10,317	9,962
Trading Asset Securities	2,028	2,596	1,888	928.53	4,241	1,970
Cash & Short-Term Investments	13,506	16,120	15,582	17,170	14,558	11,932
Cash Growth	-13.59%	3.45%	-9.25%	17.94%	22.01%	19.44%
Accounts Receivable	8,713	8,765	8,457	8,172	6,474	5,436
Other Receivables	938.84	676.66	636.27	611.57	875.26	357.09
Receivables	9,651	9,442	9,093	8,783	7,538	5,793
Inventory	6,835	7,259	7,538	6,882	5,473	5,163
Other Current Assets	2,152	1,671	1,580	2,443	2,868	2,197
Total Current Assets	32,145	34,491	33,793	35,279	30,437	25,085
Property, Plant & Equipment	24,403	23,411	22,239	16,028	13,284	13,003
Long-Term Investments	27,560	25,865	25,012	25,549	23,920	23,771
Goodwill	10,888	10,905	10,852	10,337	9,400	8,677
Other Intangible Assets	14,139	14,468	13,482	12,471	10,276	8,670
Long-Term Accounts Receivable	-	198.83	83.01	91.66	77.4	-
Long-Term Deferred Tax Assets	760.59	757.78	624.47	442.57	265.59	244.94
Long-Term Deferred Charges	6,753	6,250	4,675	4,008	3,632	3,152
Other Long-Term Assets	1,472	1,114	2,512	2,836	2,014	894.88
Total Assets	118,121	117,461	113,470	107,164	93,306	83,686
Accounts Payable	5,348	5,997	6,160	6,284	5,064	3,289
Accrued Expenses	1,812	5,408	5,414	5,577	4,807	4,234
Short-Term Debt	16,447	18,711	14,728	11,932	10,629	7,916
Current Portion of Long-Term Debt	6,232	3,983	4,422	5,230	4,986	6,771
Current Portion of Leases	-	340.98	329.53	184.41	141.5	151.08
Current Income Taxes Payable	473.9	278.7	250.63	619.34	474.22	325.43
Current Unearned Revenue	1,174	1,232	1,200	1,545	1,154	1,020
Other Current Liabilities	3,600	1,501	1,253	1,928	2,063	1,165
Total Current Liabilities	35,087	37,453	33,758	33,298	29,318	24,872
Long-Term Debt	10,931	10,444	13,505	12,100	9,049	8,476
Long-Term Leases	3,116	2,542	2,050	744.99	648.36	627.29
Long-Term Unearned Revenue	720.09	1,093	959.18	986.85	751.82	603.91
Long-Term Deferred Tax Liabilities	3,309	3,245	3,445	3,363	3,130	2,853
Other Long-Term Liabilities	4,146	2,751	3,137	2,562	2,029	269.49
Total Liabilities	57,309	57,527	56,853	53,055	44,927	37,702
Common Stock	2,670	2,671	2,672	2,672	2,563	2,563
Additional Paid-In Capital	-	16,591	16,853	16,992	14,041	15,133
Retained Earnings	31,224	29,545	27,501	26,170	23,858	20,234
Treasury Stock	-607.96	-234.38	-41.93	-53.25	-	-
Comprehensive Income & Other	14,742	-1,313	-1,300	-1,198	-1,266	-933.58
Total Common Equity	48,029	47,261	45,685	44,582	39,196	36,996
Minority Interest	12,783	12,673	10,931	9,526	9,184	8,989
Shareholders' Equity	60,812	59,934	56,616	54,109	48,380	45,984
Total Liabilities & Equity	118,121	117,461	113,470	107,164	93,306	83,686
Total Debt	36,726	36,021	35,035	30,191	25,454	23,941
Net Cash (Debt)	-23,219	-19,901	-19,453	-13,021	-10,896	-12,009
Net Cash Per Share	-8.76	-7.45	-7.29	-4.99	-4.25	-4.69
Filing Date Shares Outstanding	2,640	2,657	2,672	2,672	2,563	2,563
Total Common Shares Outstanding	2,640	2,658	2,672	2,672	2,563	2,563
Working Capital	-2,941	-2,962	34.99	1,981	1,118	212.45
Book Value Per Share	18.20	17.78	17.10	16.68	15.29	14.44
Tangible Book Value	23,001	21,888	21,351	21,774	19,519	19,649
Tangible Book Value Per Share	8.71	8.23	7.99	8.15	7.62	7.67
Land	-	943.68	951.74	201.31	203.68	196.58
Buildings	-	12,927	11,471	7,733	6,605	6,359
Machinery	-	15,392	14,026	10,700	9,197	8,270
Construction In Progress	-	3,435	4,938	4,897	3,618	4,122

Source: S&P Global Market Intelligence. Standard template. Financial Sources.